January 2025 | AIChE

Other Sites & Tools

Technical Groups

You are here

January 2025

FDA cites efficacy, safety issues in Vanda rejection

The FDA has detailed its reasons for rejecting Vanda Pharmaceuticals' gastroparesis drug tradipitant, citing insufficient eff - More -

Bioprocess developed for atezolizumab biosimilar

Researchers have developed a bioprocess to produce a biosimilar of atezolizumab, a monoclonal antibody and checkpoint inhibit - More -

Bioptimus raises $41M to advance AI for biology

Bioptimus has raised $41 million in a financing round to develop a new version of its AI-powered foundation model for biology - More -

Engineered bacteria designed to degrade PET plastic

Researchers at the University of Waterloo have engineered bacteria capable of producing PETase, an enzyme that breaks down po - More -

High levels of renewable power reduce the intensity of blackouts

As more and more energy grids turn to renewable sources of power, there have been increasing debates over whether renewable-h - More -

Nanotech shows promise for repurposing palbociclib

China Resources Pharmaceutical Group is collaborating with the Hong Kong government's Nano and Advanced Materials Institute t - More -

Emergent BioSolutions aims to stabilize with Kloxxado deal

Emergent BioSolutions has secured exclusive commercial rights to Kloxxado, an 8-mg naloxone nasal spray, from Hikma Pharmaceu - More -

Lower fuel demand tied to refineries' decline in China

China's refinery throughput declined by 1.6% in 2024, the first drop in more than two decades, excluding 2022, largely due to - More -

Product Manager - Automotive Aftermarket - FUCHS - Seoul, South Korea

Construction Engineering Intern - State of Iowa - Manchester, IA

Pages